North America Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays), Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)
The North America sepsis diagnostics market is expected to grow from US$ 279.06 million in 2021 to US$ 513.33 million by 2028. It is estimated to record a CAGR of 9.1% from 2021 to 2028.
High Incidence of Sepsis due to Increasing Nosocomial Infections Drives North America Sepsis Diagnostics Market
Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and diabetes and other chronic illnesses. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients. According to the '2020 National and State Healthcare-Associated Infections Progress Report' published by the Centers for Disease Control and Prevention (CDC) in 2021, the US recorded about 24%, 35%, and 15% increase in central line-associated bloodstream infections, ventilator-associated events, and Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, respectively, between 2019 and 2020. As per a report published by the Global Sepsis Alliance (GSA), nearly 26 million people develop sepsis every year, and ~8 million deaths are reported due to sepsis across the world. Thus, the rising bloodstream infections will increase the adoption of sepsis diagnostic products. Also, deaths are often a consequence of diarrheal diseases or lower respiratory infections. Most deaths can be prevented through early diagnosis and appropriate clinical management. Thus, the high incidence rate of sepsis is expected to boost the demand for sepsis diagnostic products, which would support the North America sepsis diagnostics market growth during the forecast period.
North America Sepsis Diagnostics Market Overview
The North America sepsis diagnostics market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American sepsis diagnostics market in 2021. In North America, the increasing adoption of technological advancements in the field of sepsis diagnostics, high adoption of innovative sepsis diagnostic technologies among medical professionals, and increasing incidence of healthcare-associated infections (HAIs) have accelerated the growth of the North America sepsis diagnostics market.
North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
North America Sepsis Diagnostics Market Segmentation
The North America sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, end user, and country.
Based on product, the North America sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.
Based on technology, the North America sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.
Based on method, the North America sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.
Based on test type, the North America sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.
Based on pathogen, the North America sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.
Based on end user, the North America sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.
Based on country, the North America sepsis diagnostics market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2021.
Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; Luminex Corporation; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the North America sepsis diagnostics market.
High Incidence of Sepsis due to Increasing Nosocomial Infections Drives North America Sepsis Diagnostics Market
Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and diabetes and other chronic illnesses. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients. According to the '2020 National and State Healthcare-Associated Infections Progress Report' published by the Centers for Disease Control and Prevention (CDC) in 2021, the US recorded about 24%, 35%, and 15% increase in central line-associated bloodstream infections, ventilator-associated events, and Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, respectively, between 2019 and 2020. As per a report published by the Global Sepsis Alliance (GSA), nearly 26 million people develop sepsis every year, and ~8 million deaths are reported due to sepsis across the world. Thus, the rising bloodstream infections will increase the adoption of sepsis diagnostic products. Also, deaths are often a consequence of diarrheal diseases or lower respiratory infections. Most deaths can be prevented through early diagnosis and appropriate clinical management. Thus, the high incidence rate of sepsis is expected to boost the demand for sepsis diagnostic products, which would support the North America sepsis diagnostics market growth during the forecast period.
North America Sepsis Diagnostics Market Overview
The North America sepsis diagnostics market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American sepsis diagnostics market in 2021. In North America, the increasing adoption of technological advancements in the field of sepsis diagnostics, high adoption of innovative sepsis diagnostic technologies among medical professionals, and increasing incidence of healthcare-associated infections (HAIs) have accelerated the growth of the North America sepsis diagnostics market.
North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
North America Sepsis Diagnostics Market Segmentation
The North America sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, end user, and country.
Based on product, the North America sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.
Based on technology, the North America sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.
Based on method, the North America sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.
Based on test type, the North America sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.
Based on pathogen, the North America sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.
Based on end user, the North America sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.
Based on country, the North America sepsis diagnostics market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2021.
Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; Luminex Corporation; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the North America sepsis diagnostics market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Sepsis Diagnostics Market – By Product
1.3.2 North America Sepsis Diagnostics Market – By Technology
1.3.3 North America Sepsis Diagnostics Market – By Method
1.3.4 North America Sepsis Diagnostics Market – By Test Type
1.3.5 North America Sepsis Diagnostics Market – By Pathogen
1.3.6 North America Sepsis Diagnostics Market – By End User
1.3.7 North America Sepsis Diagnostics Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. SEPSIS DIAGNOSTICS MARKET– NORTH AMERICA ANALYSIS
6.1 North America Sepsis Diagnostics Market Revenue Forecast and Analysis
7. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028– BY PRODUCT
7.1 Overview
7.2 North America Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – TECHNOLOGY
8.1 Overview
8.2 North America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4.3 Real-Time Cell Analysis
8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
8.4.3.1.1 Characteristics of TaqMan Assays
8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) – Case Study
8.4.3.2.1 Abstract
8.4.3.2.2 Conclusion:
8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
8.4.3.4 Sepsis diagnosis by real-time PCR
8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
8.4.4 Real-Time Cell Analysis: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Metabolomics
8.7.3.1 Metabolite Profile in Sepsis
8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
8.7.3.4.1 Genomics
8.7.3.4.2 Proteomics
8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
8.7.3.6 Role Metabolomics and Proteomics in Sepsis
8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
8.7.3.9 Metabolics in Mitochondrial Function
8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
8.7.4 Metabolomics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – METHOD
9.1 Overview
9.2 North America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – TEST TYPE
10.1 Overview
10.2 North America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – PATHOGEN
11.1 Overview
11.2 North America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – END USER
12.1 Overview
12.2 North America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – COUNTRY ANALYSIS
13.1 Overview
13.1.1 North America: North America Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.1.1.1 US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.1 Overview
13.1.1.1.2 US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.3 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.1.1.4 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.1.1.4.1 Biomarkers: Metabolomics 2019-2028
13.1.1.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.1.1.4.3 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.1.1.5 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.1.1.6 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.1.1.7 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.1.1.8 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.1.1.2 Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.1 Overview
13.1.1.2.2 Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.3 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.1.2.4 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.1.2.4.1 Biomarkers: Metabolomics 2019-2028
13.1.1.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.1.2.4.3 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.1.2.5 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.1.2.6 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.1.2.7 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.1.2.8 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.1.1.3 Mexico: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.1 Overview
13.1.1.3.2 Mexico: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.3 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.1.3.4 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.1.3.4.1 Biomarkers: Metabolomics 2019-2028
13.1.1.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.1.3.4.3 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.1.3.5 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.1.3.6 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.1.3.7 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.1.3.8 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
14. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET–INDUSTRY LANDSCAPE
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. COMPANY PROFILES
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Immunexpress Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Danaher (Beckman Coulter)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Luminex Corporation
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 THERMO FISHER SCIENTIFIC INC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 bioMerieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 T2 Biosystems, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. APPENDIX
16.1 About the Insight Partners
16.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Sepsis Diagnostics Market – By Product
1.3.2 North America Sepsis Diagnostics Market – By Technology
1.3.3 North America Sepsis Diagnostics Market – By Method
1.3.4 North America Sepsis Diagnostics Market – By Test Type
1.3.5 North America Sepsis Diagnostics Market – By Pathogen
1.3.6 North America Sepsis Diagnostics Market – By End User
1.3.7 North America Sepsis Diagnostics Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. SEPSIS DIAGNOSTICS MARKET– NORTH AMERICA ANALYSIS
6.1 North America Sepsis Diagnostics Market Revenue Forecast and Analysis
7. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028– BY PRODUCT
7.1 Overview
7.2 North America Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – TECHNOLOGY
8.1 Overview
8.2 North America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4.3 Real-Time Cell Analysis
8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
8.4.3.1.1 Characteristics of TaqMan Assays
8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) – Case Study
8.4.3.2.1 Abstract
8.4.3.2.2 Conclusion:
8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
8.4.3.4 Sepsis diagnosis by real-time PCR
8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
8.4.4 Real-Time Cell Analysis: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Metabolomics
8.7.3.1 Metabolite Profile in Sepsis
8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
8.7.3.4.1 Genomics
8.7.3.4.2 Proteomics
8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
8.7.3.6 Role Metabolomics and Proteomics in Sepsis
8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
8.7.3.9 Metabolics in Mitochondrial Function
8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
8.7.4 Metabolomics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – METHOD
9.1 Overview
9.2 North America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – TEST TYPE
10.1 Overview
10.2 North America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – PATHOGEN
11.1 Overview
11.2 North America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – END USER
12.1 Overview
12.2 North America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 – COUNTRY ANALYSIS
13.1 Overview
13.1.1 North America: North America Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.1.1.1 US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.1 Overview
13.1.1.1.2 US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.3 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.1.1.4 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.1.1.4.1 Biomarkers: Metabolomics 2019-2028
13.1.1.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.1.1.4.3 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.1.1.5 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.1.1.6 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.1.1.7 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.1.1.8 US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.1.1.2 Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.1 Overview
13.1.1.2.2 Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.3 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.1.2.4 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.1.2.4.1 Biomarkers: Metabolomics 2019-2028
13.1.1.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.1.2.4.3 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.1.2.5 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.1.2.6 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.1.2.7 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.1.2.8 Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.1.1.3 Mexico: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.1 Overview
13.1.1.3.2 Mexico: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.3 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.1.3.4 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.1.3.4.1 Biomarkers: Metabolomics 2019-2028
13.1.1.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
13.1.1.3.4.3 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.1.3.5 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.1.3.6 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.1.3.7 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.1.3.8 Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
14. NORTH AMERICA SEPSIS DIAGNOSTICS MARKET–INDUSTRY LANDSCAPE
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. COMPANY PROFILES
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Immunexpress Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Danaher (Beckman Coulter)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Luminex Corporation
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 THERMO FISHER SCIENTIFIC INC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 bioMerieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 T2 Biosystems, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. APPENDIX
16.1 About the Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. New next-generation sequencing techniques by Company
Table 2. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 3. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 4. US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 5. US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 6. US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 7. US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 8. US Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 9. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 10. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 11. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 12. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 13. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 14. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 15. Canada Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 16. Mexico Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 17. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 18. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 19. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 20. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 21. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 22. Mexico Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 23. Recent Organic Growth Strategies in Sepsis Diagnostics Market
Table 24. Inorganic Developments in the Sepsis Diagnostics Market
Table 25. Glossary of Terms
Table 1. New next-generation sequencing techniques by Company
Table 2. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 3. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 4. US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 5. US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 6. US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 7. US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 8. US Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 9. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 10. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 11. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 12. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 13. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 14. Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 15. Canada Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 16. Mexico Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 17. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 18. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 19. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 20. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 21. Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 22. Mexico Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 23. Recent Organic Growth Strategies in Sepsis Diagnostics Market
Table 24. Inorganic Developments in the Sepsis Diagnostics Market
Table 25. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Sepsis Diagnostics Market Segmentation
Figure 2. North America Sepsis Diagnostics Market, By Country
Figure 3. North America Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in North America Sepsis Diagnostics Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. North America Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. North America Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11. Instruments: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Reagents and Assays: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Blood Culture Media: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Software: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. North America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
Figure 16. Molecular Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. Polymerase Chain Reaction: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Syndromic Panel-Based Testing: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Microarrays: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Flow Cytometry: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Real-Time Cell Analysis: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Microfluidics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Immunoassay: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Biomarkers: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Metabolomics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Microbiology: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. North America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
Figure 29. Automated Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Conventional Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. North America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
Figure 32. Point-of-Care Tests: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Laboratory Tests: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. North America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
Figure 35. Bacterial Sepsis: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Fungal Sepsis: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Others: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. North America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
Figure 39. Hospitals: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Pathology and Reference Laboratories: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 41. Others: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 42. North America: North America Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 43. North America: North America Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 44. US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Mexico: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Growth Strategies in the Sepsis Diagnostics Market (%)
Figure 1. North America Sepsis Diagnostics Market Segmentation
Figure 2. North America Sepsis Diagnostics Market, By Country
Figure 3. North America Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in North America Sepsis Diagnostics Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. North America Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. North America Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11. Instruments: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Reagents and Assays: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Blood Culture Media: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Software: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. North America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
Figure 16. Molecular Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. Polymerase Chain Reaction: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Syndromic Panel-Based Testing: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Microarrays: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Flow Cytometry: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Real-Time Cell Analysis: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Microfluidics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Immunoassay: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Biomarkers: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Metabolomics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Microbiology: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. North America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
Figure 29. Automated Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Conventional Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. North America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
Figure 32. Point-of-Care Tests: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Laboratory Tests: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. North America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
Figure 35. Bacterial Sepsis: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Fungal Sepsis: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Others: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. North America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
Figure 39. Hospitals: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Pathology and Reference Laboratories: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 41. Others: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 42. North America: North America Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 43. North America: North America Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 44. US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Mexico: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Growth Strategies in the Sepsis Diagnostics Market (%)
